Cargando…

Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma

Background: Recent findings indicate that the host microbiome can have a significant impact on the development of lung cancer by inducing an inflammatory response, causing dysbiosis, and generating genome damage. The aim of this study was to search for bacterial communities specifically associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranova, Elizaveta, Druzhinin, Vladimir, Matskova, Ludmila, Demenkov, Pavel, Volobaev, Valentin, Minina, Varvara, Larionov, Alexey, Titov, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501211/
https://www.ncbi.nlm.nih.gov/pubmed/36143401
http://dx.doi.org/10.3390/life12091365
_version_ 1784795418099449856
author Baranova, Elizaveta
Druzhinin, Vladimir
Matskova, Ludmila
Demenkov, Pavel
Volobaev, Valentin
Minina, Varvara
Larionov, Alexey
Titov, Victor
author_facet Baranova, Elizaveta
Druzhinin, Vladimir
Matskova, Ludmila
Demenkov, Pavel
Volobaev, Valentin
Minina, Varvara
Larionov, Alexey
Titov, Victor
author_sort Baranova, Elizaveta
collection PubMed
description Background: Recent findings indicate that the host microbiome can have a significant impact on the development of lung cancer by inducing an inflammatory response, causing dysbiosis, and generating genome damage. The aim of this study was to search for bacterial communities specifically associated with squamous cell carcinoma (LUSC). Methods: In this study, the taxonomic composition of the sputum microbiome of 40 men with untreated LUSC was compared with that of 40 healthy controls. Next-Generation sequencing of bacterial 16S rRNA genes was used to determine the taxonomic composition of the respiratory microbiome. Results: There were no differences in alpha diversity between the LUSC and control groups. Meanwhile, differences in the structure of bacterial communities (β diversity) among patients and controls differed significantly in sputum samples (pseudo-F = 1.53; p = 0.005). Genera of Streptococcus, Bacillus, Gemella, and Haemophilus were found to be significantly enriched in patients with LUSC compared to the control subjects, while 19 bacterial genera were significantly reduced, indicating a decrease in beta diversity in the microbiome of patients with LUSC. Conclusions: Among other candidates, Streptococcus (Streptococcus agalactiae) emerges as the most likely LUSC biomarker, but more research is needed to confirm this assumption.
format Online
Article
Text
id pubmed-9501211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95012112022-09-24 Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma Baranova, Elizaveta Druzhinin, Vladimir Matskova, Ludmila Demenkov, Pavel Volobaev, Valentin Minina, Varvara Larionov, Alexey Titov, Victor Life (Basel) Article Background: Recent findings indicate that the host microbiome can have a significant impact on the development of lung cancer by inducing an inflammatory response, causing dysbiosis, and generating genome damage. The aim of this study was to search for bacterial communities specifically associated with squamous cell carcinoma (LUSC). Methods: In this study, the taxonomic composition of the sputum microbiome of 40 men with untreated LUSC was compared with that of 40 healthy controls. Next-Generation sequencing of bacterial 16S rRNA genes was used to determine the taxonomic composition of the respiratory microbiome. Results: There were no differences in alpha diversity between the LUSC and control groups. Meanwhile, differences in the structure of bacterial communities (β diversity) among patients and controls differed significantly in sputum samples (pseudo-F = 1.53; p = 0.005). Genera of Streptococcus, Bacillus, Gemella, and Haemophilus were found to be significantly enriched in patients with LUSC compared to the control subjects, while 19 bacterial genera were significantly reduced, indicating a decrease in beta diversity in the microbiome of patients with LUSC. Conclusions: Among other candidates, Streptococcus (Streptococcus agalactiae) emerges as the most likely LUSC biomarker, but more research is needed to confirm this assumption. MDPI 2022-09-01 /pmc/articles/PMC9501211/ /pubmed/36143401 http://dx.doi.org/10.3390/life12091365 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Baranova, Elizaveta
Druzhinin, Vladimir
Matskova, Ludmila
Demenkov, Pavel
Volobaev, Valentin
Minina, Varvara
Larionov, Alexey
Titov, Victor
Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title_full Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title_fullStr Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title_full_unstemmed Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title_short Sputum Microbiome Composition in Patients with Squamous Cell Lung Carcinoma
title_sort sputum microbiome composition in patients with squamous cell lung carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501211/
https://www.ncbi.nlm.nih.gov/pubmed/36143401
http://dx.doi.org/10.3390/life12091365
work_keys_str_mv AT baranovaelizaveta sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT druzhininvladimir sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT matskovaludmila sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT demenkovpavel sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT volobaevvalentin sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT mininavarvara sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT larionovalexey sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma
AT titovvictor sputummicrobiomecompositioninpatientswithsquamouscelllungcarcinoma